Celgene (CELG) stock boosted on purchase of Receptos

Celgene Corporation (NASDAQ: CELG) gained 9.5% to $134.50 after the company announced its plans to acquire Receptos for $7.2 billion and lifted its earnings forecast for 2015. Share volume was 10.2 million, overwhelming an all-day average of 4.4 million